NEW YORK, Nov. 17, 2010 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
This report analyzes the worldwide markets for Anticoagulants in US$ Million by the following segments : Oral Anticoagulants, and Injectable Anticoagulants (Unfractionated Heparin, & Low Molecular Weight Heparin). The report provides separate comprehensive analytics for the US, Japan, Europe and Rest of World. Annual estimates and forecasts are provided for each region for the period 2007 through 2015. A seven-year historic analysis is also provided for these markets.The report profiles 51 companies including many key and niche players such as AstraZeneca PLC, Bristol-Myers Squibb Company, GlaxoSmithKline plc, LEO Pharmaceutical Products, Mitsubishi Tanabe Pharma Corporation, Pfizer Inc, Sanofi-Aventis. Teva Pharmaceutical Industries Ltd., and Teva Pharmaceuticals USA. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
A GLOBAL STRATEGIC BUSINESS REPORT
1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1
Study Reliability and Reporting Limitations 1
Data Interpretation & Reporting Level 2
Quantitative Techniques & Analytics 3
Product Definitions And Scope of Study 3
2. INDUSTRY OVERVIEW 4
A Rapidly Evolving Market 4
Current and Future Analysis 4
Warfarins & Heparins: Dominating Anticoagulants Market 5<
Copyright©2010 PR Newswire.
All rights reserved